Printer Friendly

Browse Biotechnology industries topic

Subtopics (170)

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Exelixis' Collaborator Daiichi Sankyo Launches Minnebro Tablets in Japan. May 17, 2019 444
Alligator Bioscience announces showcasing of ATOR-1015 phase I study outline at ASCO. May 17, 2019 278
Alligator Bioscience announces showcasing of ATOR-1015 phase I study outline at ASCO. May 17, 2019 282
Alligator Bioscience announces showcasing of ATOR-1015 phase I study outline at ASCO. May 17, 2019 283
Adverum Biotechnologies announces lift of clinical hold on ADVM-022. May 16, 2019 246
MorphoSys confirms primary endpoint of L-MIND study was met. May 16, 2019 113
Alligator Bioscience announces that data of ADC-1013 from phase I clinical trial will be presented at ASCO. May 16, 2019 303
Alligator Bioscience announces that data of ADC-1013 from phase I clinical trial will be presented at ASCO. May 16, 2019 299
Scottish Mortgage Investment Trust Beats Benchmark; Sanguine On Brexit. May 16, 2019 566
Daiichi Sankyo Company launches MINNEBRO. May 15, 2019 116
Daiichi Sankyo Company launches MINNEBRO. May 15, 2019 112
Harnessing Heat Capacity in Enzyme Catalysis using 3D Printed Polymers - Developing a technology suite for the protein Biotech industry. May 15, 2019 468
Roche, Spark Therapeutics intend to refile premerger notification around May 23. May 14, 2019 396
Dare Bioscience reports Q1 EPS (27c), consensus (30c). Financial report May 14, 2019 196
Switzerland : Swiss biotech industry growing. May 13, 2019 386
16 public sector companies closed down so far, LHC told. May 11, 2019 254
United States : Pfizer Acquires Clinical-stage Biotech Therachon. May 11, 2019 603
AmpliPhi Biosciences, C3J Therapeutics Close Merger to Expand Bacteriophage Therapeutics Development. May 10, 2019 321
AmpliPhi Biosciences, C3J Therapeutics Close Merger to Expand Bacteriophage Therapeutics Development. May 10, 2019 322
Deal snapshot: AMPLIPHI BIOSCIENCES, C3J THERAPEUTICS CLOSE MERGER TO EXPAND BACTERIOPHAGE THERAPEUTICS DEVELOPMENT. May 10, 2019 114
C3J Therapeutics and AmpliPhi Biosciences complete merger. May 10, 2019 190
C3J Therapeutics and AmpliPhi Biosciences complete merger. May 10, 2019 186
Pfizer Acquires Swiss Biotech Therachon for USD 810m. May 9, 2019 216
AmpliPhi Biosciences Wins Shareholder Nod for Business Combination with C3J Therapeutics. May 9, 2019 347
2 biotech companies moving lab to UNO. May 9, 2019 345
BioGaia profit down by 18% in Q1 2019. Financial report May 9, 2019 190
BioGaia profit down by 18% in Q1 2019. May 9, 2019 188
BioGaia profit down by 18% in Q1 2019. Financial report May 9, 2019 191
Twist Bioscience prices USD78.8m public offering of common shares. May 9, 2019 256
PharmaCyte Biotech Advances Manufacturing Process for Clinical Trial in Pancreatic Cancer. May 9, 2019 699
Pfizer Acquires Swiss Biotech Therachon for USD 810m. May 9, 2019 212
AmpliPhi Biosciences Wins Shareholder Nod for Business Combination with C3J Therapeutics. May 9, 2019 346
Amicus reports Q1 EPS (56c), consensus (31c). Financial report May 8, 2019 184
Dare Bioscience announces DARE-FRT1 data published. May 8, 2019 118
United Therapeutics and DEKA partnership win US FDA clearance for Remodulin for treating PAH. May 8, 2019 272
PharmaCyte Biotech advances manufacturing process for pancreatic cancer product used in clinical trial. May 8, 2019 163
United Therapeutics and DEKA partnership win US FDA clearance for Remodulin for treating PAH. May 8, 2019 270
United Therapeutics and DEKA partnership win US FDA clearance for Remodulin for treating PAH. May 8, 2019 268
PharmaCyte Biotech advances manufacturing process for pancreatic cancer product used in clinical trial. May 8, 2019 159
Twist Bioscience proposes public offering of 3,000,000 shares of common stock. May 7, 2019 212
Active Biotech reports on election committee's board proposals. May 3, 2019 475
Active Biotech reports on election committee's board proposals. May 3, 2019 476
Sinovant Sciences' Derazantinib's Clinical Trial Application Approved by the China National Medical Products Administration. May 2, 2019 458
United States : Neurocrine Biosciences to Present Data Analyses on INGREZZA and Opicapone at the 2019 American Academy of Neurology Annual Meeting. May 2, 2019 185
Meridian Bioscience to Acquire Molecular Diagnostics Business of GenePOC. May 2, 2019 228
Meridian Bioscience to Acquire Molecular Diagnostics Business of GenePOC. May 2, 2019 230
Seattle Genetics (NASDAQ: SGEN). May 2, 2019 1414
Meridian Bioscience to Acquire Business of GenePOC; Adds Molecular Diagnostics Platform. May 1, 2019 537
Meridian Bioscience to Acquire Business of GenePOC; Adds Molecular Diagnostics Platform. May 1, 2019 540
Exelixis initiates COSMIC-313 trial. May 1, 2019 163
MAXINOVEL INHIBITOR SIMILAR EFFICACY TO PD-L1. May 1, 2019 173
TEMPO EXPANDS IPSC-DERIVED CELL MODELS. May 1, 2019 266
Debiopharm announces acquisition agreement with Meridian Bioscience. May 1, 2019 176
Debiopharm announces acquisition agreement with Meridian Bioscience. May 1, 2019 172
Meridian Bioscience announces agreement to acquire business of GenePOC. Apr 30, 2019 130
Adaptive Biotechnologies Names Baldo as Chief Medical Officer. Apr 30, 2019 317
Sinovant announces China approval of derazantinib's clinical trial application. Apr 30, 2019 101
United States : Neurocrine Biosciences Reports First Quarter 2019 Financial Results. Financial report Apr 30, 2019 170
United Therapeutics wins US FDA approval of XPS & Steen Solution for centralised Ex-Vivo lung perfusion services. Apr 30, 2019 270
United Therapeutics wins US FDA approval of XPS & Steen Solution for centralised Ex-Vivo lung perfusion services. Apr 30, 2019 268
United Therapeutics wins US FDA approval of XPS & Steen Solution for centralised Ex-Vivo lung perfusion services. Apr 30, 2019 266
Amgen UK (NYSE: AMGN). Apr 30, 2019 2265
Bristol Myers Squibb UK. Apr 30, 2019 1912
Korean Firm To Develop Stem Cell-Based Atopic Dermatitis Drug With Kangstem Biotech. Apr 29, 2019 141
Korean Firm To Develop Stem Cell-Based Atopic Dermatitis Drug With Kangstem Biotech. Apr 29, 2019 141
Hear from Amgen Speaking at SMi's 4th Annual Conference and Exhibition: Pre-Filled Syringes West Coast 2019. Conference news Apr 27, 2019 608
Reagents And Consumables For Sequencing Reactions On The Genetic Analyzer Abi 3130 Genetic Analyzer, Manufactured By Applied Biosystems. Apr 27, 2019 111
Active Biotech reduces loss in Q1 2019. Financial report Apr 26, 2019 134
Active Biotech reduces loss in Q1 2019. Apr 26, 2019 132
Active Biotech reduces loss in Q1 2019. Financial report Apr 26, 2019 135
Immunovia widens loss in Q1 2019. Financial report Apr 25, 2019 172
XVIVO Perfusion swings to loss in Q1 2019. Financial report Apr 25, 2019 194
Biotage's result up by 5.9% in Q1 2019. Brief article Apr 25, 2019 174
Seattle Genetics (NASDAQ: SGEN). Apr 25, 2019 1989
Chugai Pharmaceutical Company Limited. Apr 24, 2019 549
Supply Of Consumables Compatible With The Platform Genechip System 3000 Of Applied Biosystems. Apr 24, 2019 106
Yield10 Bioscience receives notice of allowance from USPTO for C3003. Apr 23, 2019 108
KalVista Pharmaceuticals Names Soland to Board of Directors. Apr 23, 2019 334
Amgen (NASDAQ: AMGN). Apr 23, 2019 2287
Genentech (SIX: RO, ROG; OTCQX: RHHBY). Apr 23, 2019 256
Amgen UK (NYSE: AMGN). Apr 23, 2019 2265
Bristol Myers Squibb UK. Apr 23, 2019 1912
Charting a new course. Apr 22, 2019 1414
Western Blotting Market Offering Trends, Share, Size, Growth by 2021. Apr 18, 2019 1314
Western Blotting Market Offering Trends, Share, Size, Growth by 2021. Apr 18, 2019 1301
CSR: Renmoney Staff Donate Blood In Partnership With LifeBank. Apr 18, 2019 278
Paragon acquisition gives a jolt to Md. biotech industry. Apr 17, 2019 703
Alligator Bioscience reports on nomination committee's proposal for the annual shareholders' meeting. Apr 17, 2019 490
Alligator Bioscience reports on nomination committee's proposal for the annual shareholders' meeting. Apr 17, 2019 491
Alnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of Lumasiran for the Treatment of Primary Hyperoxaluria. Apr 17, 2019 1081
INVO Bioscience incurs higher net loss of USD3.06m in 2018. Financial report Apr 17, 2019 142
BioPorto's board decides to issue 5,100,000 new warrants. Brief article Apr 16, 2019 308
GenScript-Legend Biotech Commercial Manufacturing Center. Apr 16, 2019 309
Seattle Genetics (NASDAQ: SGEN). Apr 16, 2019 1986
Amgen UK (NYSE: AMGN). Apr 16, 2019 2269
Bristol Myers Squibb UK. Apr 16, 2019 1907
Amgen (NASDAQ: AMGN). Apr 15, 2019 2287
Genentech (SIX: RO, ROG; OTCQX: RHHBY). Apr 15, 2019 255
McKesson Corporation (NYSE: MCK). Apr 15, 2019 1757
ThermoGenesis Cell Processing Systems Available In Thailand. Apr 15, 2019 118
ThermoGenesis Cell Processing Systems Available In Thailand. Apr 15, 2019 118
Twist Bioscience, iGEM partner to provide synthetic DNA for competition. Apr 15, 2019 182
Adverum Biotechnologies announces clinical hold on ADVM-022 IND. Apr 15, 2019 182
Lung Cancer Diagnostics Market Increasing Awareness Programs for Lung Cancer to Drive Growth. Apr 15, 2019 664
Moleculin Biotech signs drug trial contract with Emory University. Apr 12, 2019 104
Aurinia Names Greenleaf as Chief Executive Officer and Board Director. Apr 12, 2019 813
Paragon opens new biotech manufacturing facility near BWI. Apr 12, 2019 272
United States : Senator Roberts Receives Lifetime Achievement Award from BIO. Apr 11, 2019 270
Seattle Genetics (NASDAQ: SGEN). Apr 11, 2019 1986
Puma Biotechnology announces inducement restricted stock unit to three new non-executive employees under Nasdaq Listing Rule 5635(c)(4). Apr 10, 2019 182
Celltrion collaborates with iProgen Biotech. Apr 9, 2019 260
Celltrion collaborates with iProgen Biotech. Apr 9, 2019 256
Senner Elected to Cortexyme Board of Directors. Apr 9, 2019 229
Puma Biotechnology expands two additional cohorts for Neratinib Phase II clinical trial. Apr 8, 2019 182
Twist Bioscience announces strategic collaboration with LakePharma. Apr 8, 2019 177
Alnylam concludes research and option agreement with Sanofi. Apr 8, 2019 220
Alnylam concludes research and option agreement with Sanofi. Apr 8, 2019 218
Puma Biotechnology expands two additional cohorts for Neratinib Phase II clinical trial. Apr 8, 2019 178
Twist Bioscience announces strategic collaboration with LakePharma. Apr 8, 2019 173
Alnylam concludes research and option agreement with Sanofi. Apr 8, 2019 216
Dare Bioscience announces publication of DARE-HRT1 data. Apr 8, 2019 223
Advaxis Raises USD 10m from Common Stock Offering. Apr 5, 2019 361
Novartis sues Amgen over migraine treatment Aimovig. Vecchione, Anthony Apr 4, 2019 257
Twist Bioscience, LakePharma form strategic collaboration for antibody discovery. Apr 4, 2019 120
Advaxis prices public offering at USD4.00 per share. Apr 4, 2019 161
Advaxis prices public offering at USD4.00 per share. Apr 4, 2019 159
Puma Biotechnology signs license agreement with Pierre Fabre. Apr 3, 2019 212
Puma Biotechnology signs license agreement with Pierre Fabre. Apr 3, 2019 208
Advaxis Inc to launch public offering of common stock. Apr 3, 2019 155
Advaxis Inc to launch public offering of common stock. Apr 3, 2019 159
Advaxis Inc to launch public offering of common stock. Apr 3, 2019 157
Roche, Spark Therapeutics withdraw, refile premerger notification. Apr 3, 2019 511
Meridian Bioscience downgraded to Sell from Hold at Canaccord. Apr 3, 2019 115
United States : Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinsons Disease in the Annals of Neurology. Apr 3, 2019 184
United States : Congresswoman Speier, Fire Chief, Engineering Dean, Open Water Swimmer, Broadcast Journalists to Inspire Students to Pursue Dreams. Apr 3, 2019 156
Nordic Nanovector announces promising results from preclinical research collaboration to develop novel CD37-targeting alpha therapy for B-cell tumours. Brief article Apr 2, 2019 215
Meridian Bioscience sees Q2 revenue $50.0M, consensus $56.37M. Financial report Apr 2, 2019 222
Meridian Bioscience sees FY19 non-GAAP EPS 60c-65c, consensus 76c. Apr 2, 2019 119
Seattle Genetics Completes Enrollment in Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer. Apr 2, 2019 526
Roth Capital Partners names co-head of Biotechnology Research. Apr 1, 2019 227
Roth Capital Partners names co-head of Biotechnology Research. Apr 1, 2019 225
Positive Phase 2 Study Released for Trofinetide in Pediatric Rett Syndrome Published in Neurology, the Medical Journal of the American Academy of Neurology. Clinical report Apr 1, 2019 813
Meet and Network with Pharma and Biotech Industry Leaders Next Week in Boston at SMi's Pre-Filled Syringes East Coast Conference. Conference news Apr 1, 2019 326
Seattle Genetics and Astellas Tout Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. Apr 1, 2019 731
Seattle Genetics and Astellas announce positive top-line results from enfortumab vedotin cancer trial. Mar 29, 2019 291
Seattle Genetics and Astellas announce positive top-line results from enfortumab vedotin cancer trial. Mar 29, 2019 287
Advaxis approves one-for-15 reverse common stock split. Mar 29, 2019 236
Advaxis approves one-for-15 reverse common stock split. Mar 29, 2019 234
From scouting to STEM: GIRL SCOUTS, ARMI LAUNCH COLLABORATION. Brief article Mar 29, 2019 176
Discover Dubai's science and research-focused business community. Mar 28, 2019 1147
Orphazyme reports on AGM and board meeting. Brief article Mar 28, 2019 213
5 Microbiology Spotlight Sessions to be Covered at SMi's 3rd Annual Pharma Microbiology West Coast. Mar 27, 2019 531
Arcus Biosciences Names Hemrajani as Chief Operating and Financial Officer. Mar 27, 2019 375
Acadia says Phase 2 Trofinetide results published in Neurology. Clinical report Mar 27, 2019 244
Sandoz unveils treprostinil injection in the US PAH market. Mar 26, 2019 198
Sandoz unveils treprostinil injection in the US PAH market. Mar 26, 2019 194
Advaxis Granted US Patent Relating to Axalimogene Filolisbac. Mar 26, 2019 400
White Collar Corner: Fraud, Executive Law 63(12)'s summary enforcement procedures and the FCA. Mar 26, 2019 1320
Germany : Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China. Mar 25, 2019 433
Sana Biotechnology names new executive vice president, Technical Operations. Mar 22, 2019 189
Sana Biotechnology names new executive vice president, Technical Operations. Mar 22, 2019 185
Scientists CLONE adorable police dog dubbed 'Sherlock Holmes'; The dog was cloned from a police sniffer dog by the Beijing-based Sinogene Biotechnology Company and the Yunnan Agricultural University. Mar 22, 2019 278
Imago BioSciences Raises USD 40m Series B Financing Led by Omega Funds. Mar 22, 2019 405
Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for HER2 (ERBB2) Mutant, Metastatic Cervical Cancer. Mar 21, 2019 497
FDA Approves Genentech's Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-Stage Small Cell Lung Cancer. Mar 21, 2019 390
Alligator Bioscience to present new preclinical data for the drug candidate ATOR-1017 at the 4th Annual Immuno-oncology Summit Europe, London. Mar 19, 2019 236
AbbVie: FDA puts partial clinical hold on venetoclax program. Mar 19, 2019 275
China National Biotec Group, ImmunoBiology Enter Licensing Agreement to Co-Develop Next Generation Vaccine against Pneumococcal Disease in Greater China. Mar 19, 2019 524
MorphoSys, I-Mab Biopharma initiate phase 2 study of TJ202 for multiple myeloma. Mar 19, 2019 118
Dare Bioscience announces publication of clinical findings for DARE-VVA1. Mar 18, 2019 622
Sinergium Biotech Antigen Production Plant. Mar 18, 2019 258
ViaCyte Restructures Board. Mar 18, 2019 123
Deal snapshot: BIOLIFE SOLUTIONS EXPANDS CELL AND GENE THERAPY TOOLS PORTFOLIO WITH ACQUISITION OF ASTERO BIO. Mar 15, 2019 125
Bionano Genomics Enters Into Debt and Equity Financing Agreements Totaling USD 41.5m in Commitments. Mar 15, 2019 675
USRM announces rise of 21% in revenue and 26% in profit margin for 2018. Financial report Mar 14, 2019 127
USRM announces rise of 21% in revenue and 26% in profit margin for 2018. Mar 14, 2019 125
Active Biotech enters into SEK275m agreement regarding sale of the company's property in Lund. Mar 14, 2019 316
Active Biotech enters into SEK275m agreement regarding sale of the company's property in Lund. Mar 14, 2019 317
SOM Biotech closes a EUR 7m financing round led by pharmaceutical holding company. Mar 14, 2019 246
SOM Biotech closes a EUR 7m financing round led by pharmaceutical holding company. Mar 14, 2019 244
Automated label Inspection Machines Market Shares, Strategies and Forecast Worldwide, 2018 to 2028. Mar 14, 2019 1338
Tenaya Therapeutics Names Tingley As Chief Medical Officer, Kim As SVP. Mar 14, 2019 828
United States : Neurocrine Biosciences Reports Positive Interim Results from Phase II Study of NBI-74788 in Adults with Classic Congenital Adrenal Hyperplasia. Mar 13, 2019 493
United States : Neurocrine Biosciences to Present at Upcoming Healthcare Conferences. Conference news Mar 13, 2019 123
Canada : Technopole maritime du Qubec: a key partner and catalyst for the marine science and marine technology and biotechnology sector. Mar 13, 2019 215
Transcenta Holding names Yi Gu as SVP. Mar 12, 2019 123
Transcenta Holding names Yi Gu as SVP. Mar 12, 2019 121
Transcenta Holding names Yi Gu as SVP. Mar 12, 2019 119
Stellar Biotechnologies enters into share exchange agreement with Edesa Biotech. Mar 11, 2019 289
Stellar Biotechnologies enters into share exchange agreement with Edesa Biotech. Mar 11, 2019 285
Alnylam Submits CTA Application for ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension in High Unmet Need Settings. Mar 11, 2019 617
Dare Bioscience receives second award of $982,851 from NICHD. Mar 11, 2019 144
United States : Accenture to Acquire ESP to Help Life Sciences Clients Digitize and Transform Manufacturing Operations. Mar 11, 2019 586
Switzerland : Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash. Mar 9, 2019 503
Switzerland : Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions. Mar 9, 2019 345
Alnylam Touts Positive Topline Results from ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria. Mar 8, 2019 929
Stellar Biotechnologies, Edesa Biotech sign share exchange agreement. Mar 8, 2019 235
Roche commences tender offer for Spark Therapeutics shares for $114.50/share. Mar 7, 2019 219
FDA Accepts Genentech's Supplemental New Drug Application for Xofluza for the Treatment of Influenza in People at High Risk of Complications. Mar 7, 2019 354
International Stem Cell qualifies to trade on OTCQX. Mar 7, 2019 151
International Stem Cell qualifies to trade on OTCQX. Mar 7, 2019 149
International Stem Cell qualifies to trade on OTCQX. Mar 7, 2019 147
Report finds New Jersey among top US markets for life sciences sector. Perry, Jessica Mar 6, 2019 347
Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020. Mar 6, 2019 594
Health Canada Okays ThermoGenesis' PXP System For Automated Processing Of Cells. Mar 4, 2019 220
Korean Biotech Selects Orgenesis' Subsidiary To Manufacture Dermatitis Treatment In Europe. Mar 4, 2019 265
Health Canada Okays ThermoGenesis' PXP System For Automated Processing Of Cells. Mar 4, 2019 220
Korean Biotech Selects Orgenesis' Subsidiary To Manufacture Dermatitis Treatment In Europe. Mar 4, 2019 265
The pioneer of India's biotech industry. Mar 3, 2019 908
Zealand Pharma registers change in executive management with Danish Business Authority. Brief article Mar 1, 2019 121
FDA Approves Herceptin Hylecta for Subcutaneous Injection in Certain HER2-Positive Breast Cancers. Mar 1, 2019 510
HERCEPTIN HYLECTA APPROVED FOR HER2 INJECION. Mar 1, 2019 427
WuXi Biologies, Amicus Enter Exclusive Mfg. Pact. Mar 1, 2019 330
Mycobacterium avium in Community and Household Water, Suburban Philadelphia, Pennsylvania, USA, 2010-2012. Lande, Leah; Alexander, David C.; Wallace, Richard J., Jr.; Kwait, Rebecca; Iakhiaeva, Elena; Willia Mar 1, 2019 6551
New Zealand : New Zealand urgently needs a biotech strategy. Feb 28, 2019 395
United States : Weil's 2018 Verinata Trial Victory Recognized as a Top Verdict by Daily Journal. Feb 28, 2019 361
Roche to acquire Spark Therapeutics. Feb 27, 2019 118
Roche to acquire Spark Therapeutics. Feb 27, 2019 114
Acadia price target raised to $30 from $25 at Piper Jaffray. Feb 27, 2019 125
ILSE joins global network to combat antibiotic-resistant superbugs. Perry, Jessica Feb 26, 2019 394
Gracell Biotechnologies concludes USD85m Series B financing. Feb 26, 2019 191
Gracell Biotechnologies concludes USD85m Series B financing. Feb 26, 2019 187
Asana BioSciences Strengthens Leadership Team as ASN002 Phase 2b RADIANT Trial in Atopic Dermatitis Advances with a Second Positive DSMB Recommendation. Feb 26, 2019 552
Roche to Acquire Spark Therapeutics in Deal Valued at USD 4.8bn. Feb 26, 2019 283
Roche to Acquire Spark Therapeutics in Deal Valued at USD 4.8bn. Feb 26, 2019 283
Black Diamond Networks Acquires BioSciences Division of American Personnel Staffing. Feb 26, 2019 152
Black Diamond Networks Acquires BioSciences Division of American Personnel Staffing. Feb 26, 2019 164
Morphic Therapeutic signs research and development collaboration with Janssen Biotech. Feb 25, 2019 203
Morphic Therapeutic signs research and development collaboration with Janssen Biotech. Feb 25, 2019 199
Roche Buys Firm Selling Most Expensive Medicine In US. Feb 25, 2019 476
Roche acquires Spark Therapeutics for $114.50 per share, a 122% premium. Feb 25, 2019 167
ArQule announces publication of clinical data with miransertib. Feb 25, 2019 123
ThermoGenesis granted Health Canada approval of PXP System. Feb 25, 2019 116
Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate. Feb 25, 2019 278
ArQule Clinical Data Published on Miransertib in Proteus Syndrome. Feb 25, 2019 485
Trial Planned For Cell Therapy Derived From Engineered Stem Cell. Feb 25, 2019 444
Results From French Clinical Trial Of Cell Therapy In Crohn's Disease. Feb 25, 2019 512
Company Reports Successful Results In Traumatic Brain Injury. Financial report Feb 25, 2019 266
NuAxon Bioscience Welcomes Advisory Board Member. Feb 24, 2019 360
SMi's Pharma Microbiology West Coast 2019 Chair and Speakers Announced. Feb 23, 2019 791
Life Care Group Inc. Launches Pet First Aid Kit. Feb 22, 2019 313
United Kingdom : Parker Bioscience Filtration enhances UK site with launch of its SciLog Suite. Feb 22, 2019 454
Base Pair Biotechnologies awarded the fast track SBIR grant to develop point-of-care tests for opioids in newborns. Feb 22, 2019 280
Base Pair Biotechnologies awarded the fast track SBIR grant to develop point-of-care tests for opioids in newborns. Feb 22, 2019 276
United Kingdom : Parker Bioscience Filtration boosts UK site with the opening of new cleanroom. Feb 22, 2019 431
Merck to acquire Immune Design for $300 million. Brief article Feb 21, 2019 223
Empire Genomics Names Watson as CEO. Feb 20, 2019 634
Hummingbird Bioscience welcomes James Allison and Padmanee Sharma to SAB. Feb 19, 2019 272
Advaxis Enrolls First Patient in its Phase 1/2 Trial for ADXS-HOT in the Treatment of Non-Small Cell Lung Cancer. Feb 19, 2019 413
Puma Biotechnology announces stock options to three new non-executive employees under Nasdaq Listing Rule 5635(c)(4). Feb 18, 2019 187
Puma Biotechnology announces stock options to three new non-executive employees under Nasdaq Listing Rule 5635(c)(4). Feb 18, 2019 183
FDA Clears IND Application For Therapy Derived From Engineered Stem Cells. Feb 18, 2019 444
Clinical Trial Results For Cell Therapy In Crohn's Disease. Feb 18, 2019 509
ISCO Reports Successful Results In Traumatic Brain Injury. Financial report Feb 18, 2019 266
FDA Clears IND Application For Therapy Derived From Engineered Stem Cells. Feb 18, 2019 444
Clinical Trial Results For Cell Therapy In Crohn's Disease. Feb 18, 2019 509
ISCO Reports Successful Results In Traumatic Brain Injury. Financial report Feb 18, 2019 267
United States : HOOKIPA Appoints Michael A. Kelly as Independent Director. Feb 16, 2019 328
Bioscience major HiMedia Labs bags 'Pride of Maharashtra' award. Feb 15, 2019 162
Active Biotech reduces loss in 2018. Feb 15, 2019 109
Active Biotech reduces loss in 2018. Feb 15, 2019 110
Discovery Life Sciences Launches European Expansion with Acquisition. Feb 14, 2019 292
Exelixis to Initiate Phase 1 Clinical Development of XL092, First New Compound to Enter the Clinic from Reinitiated Discovery Efforts. Feb 14, 2019 276
Sanofi, Regeneron win IPR challenge to Amgen IL-4 patent. Feb 14, 2019 130
Amicus, WuXi sign exclusive manufacturing partnership. Feb 11, 2019 287
Seattle Genetics Achieves USD 30m Milestone Payment for European Commission Approval of Adcetris in Frontline Hodgkin Lymphoma. Feb 11, 2019 456
Alnylam's Phase 1 Givosiran Data Published in The New England Journal of Medicine. Feb 8, 2019 1411
Donation from Bavarian Red Cross and Argeta company for migrants. Feb 7, 2019 234
Neurocrine Biosciences achieves higher net income of USD21.1m for 2018. Feb 6, 2019 239
Neurocrine Biosciences achieves higher net income of USD21.1m for 2018. Feb 6, 2019 237
Neurocrine Biosciences achieves higher net income of USD21.1m for 2018. Feb 6, 2019 235
Falco Biosystems, Promega Corp.'s MSI-IVD Kit Collaboration Obtains Approved Companion Diagnostic Status in Japan. Feb 6, 2019 338
Blue Diamond Ventures Acquires Harvest 360 Technologies to Accelerate Position in Cannabis Biotech. Feb 5, 2019 271
Blue Diamond Ventures Acquires Harvest 360 Technologies to Accelerate Position in Cannabis Biotech. Feb 5, 2019 275
Genentech Submits Supplemental Biologics License Application to FDA for Kadcyla for Adjuvant Treatment of People with HER2-Positive Early Breast Cancer with Residual Disease After Neoadjuvant Treatment. Feb 5, 2019 212
Active Biotech announces receipt of an indicative bid of SEK275m for its property in Lund. Feb 4, 2019 259
Active Biotech announces receipt of an indicative bid of SEK275m for its property in Lund. Feb 4, 2019 260
IQVIA launches IQVIA Biotech. Feb 4, 2019 153
Canada : Sugarbud Announces Strategic Relationship With Phylos Bioscience Inc. Regarding the Characterization and Analysis of Sugarbuds Genetic Library. Feb 4, 2019 200
U.S. Patient Protects ISCO's Anti-Aging Business. Feb 4, 2019 156
U.S. Patent: Protects ISCO's Anti-Aging Business. Feb 4, 2019 156
United States : WilmerHale Advises Voyager Therapeutics in Strategic Collaboration With Neurocrine Biosciences. Feb 2, 2019 168
Alexion, Caelum Biosciences Team to Develop Targeted Therapy for Light Chain Amyloidosis. Feb 1, 2019 746
Phyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy. Feb 1, 2019 558
IGM Biosciences welcomes M. Kathleen Behrens, PhD to board. Feb 1, 2019 222
Reverse-Aging Biotechnology Regeron. Feb 1, 2019 539
PIERIANDX SIGNS MULTI-YEAR AGREEMENT WITH ILLUMINA. Feb 1, 2019 471
Hitachi Chemical to expand global footprint with Apceth Biopharma acquisition. Perry, Jessica Jan 31, 2019 307
Alligator Bioscience announces publication of clinical phase I data for ADC-1013 in the International Journal of Cancer. Jan 30, 2019 245
Alligator Bioscience announces publication of clinical phase I data for ADC-1013 in the International Journal of Cancer. Jan 30, 2019 246
Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab. Jan 30, 2019 298
Promega Enters License Agreement with Broad Institute to Access CRISPR-Cas9 Gene Editing Technology. Jan 30, 2019 279
Genentech to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer's Disease. Jan 30, 2019 673
Neurocrine, Voyager Therapeutics form development, commercialization agreement. Jan 29, 2019 383
European Diabetes Research Coordinator, Joins Company In Clinical Trial. Jan 28, 2019 600
Genmab's announces patents asserted by MorphoSys against DARZALEX in the US declared invalid by summary judgment. Jan 28, 2019 240
Genmab's announces patents asserted by MorphoSys against DARZALEX in the US declared invalid by summary judgment. Jan 28, 2019 238
Genmab's announces patents asserted by MorphoSys against DARZALEX in the US declared invalid by summary judgment. Jan 28, 2019 241
Cantargia reports treatment of first patient with antibody CAN04 in the phase IIa part of CANFOUR trial. Jan 28, 2019 335
Genmab says patents asserted against Darzalex in U.S. declared invalid. Jan 28, 2019 178

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters